Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Dorairaj Prabhakaran

General Cardiology

View

Dr. Trey Woods

General Cardiology · Emory Healthcare

View

Dr. Rishi Wadhera

General Cardiology · BIDMC

View

Dr. Robert Harrington

General Cardiology · WCM

View

Dr. Mike Gaziano

General Cardiology · BWH

View

Dr. Tyler Gluckman

General Cardiology · Providence

View

Dr. Cayla Pichan

General Cardiology · UT Southwestern

View

Dr. Sanjiv Kaul

General Cardiology · OHSU

View

Dr. Emily Lau

General Cardiology · MGH

View

Dr. Sarah Ashley

General Cardiology · Emory University Hospital

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Racial Differences in Palliative Care Use in Heart Failure Decedents.

    Mar 15, 2024DOI: 10.1016/j.cardfail.2024.02.018Journal ArticleJCF

    Written by: Sarah H CrossNeal W DickertAlanna A MorrisJabeen TajModele O OgunniyiDio Kavalieratos

    Find these authors on Roon

    MO
    Dr. Modele Ogunniyi
    General Cardiology · Emory University

    Methods

    This retrospective cohort study used records from individuals in the Georgia Death Index (GDI) who died between 2012 and 2018 with International Classification of Diseases (ICD), Tenth Revision codes I50.XX listed as primary cause of death and who had had a hospitalization at an Emory Healthcare facility. Individuals in GDI were matched to medical records in the Emory University Clinical Data Warehouse (CDW) using Social Security Number, date of birth, and last name. Emory Healthcare had five urban hospitals, each staffed with a PC team. We obtained date of death from the GDI as not all individuals died in an Emory facility. As this study used decedents’ medical records, it was deemed by the Emory University IRB to be exempt from review.Our primary outcome was receipt of PCC determined by the presence of ICD-9 code V66.7 or ICD-10 code Z51.5 in the medical record. (For diagnoses on or after October 1, 2015, when ICD-10 was implemented, our Clinical Data Warehouse includes both ICD-9 and ICD-10 codes.) ICD diagnostic codes have been found to have high sensitivity and specificity in identifying specialist PCC in HF patients’ electronic medical records.7 Patient-level demographics included race, gender, age at death, insurance, and death year. Race and age at death were obtained from the GDI. Insurance was obtained from the medical record. Ethnicity was not included due to inconsistent recording. We also included several measures of patient healthcare utilization: inotropic therapy, hospital admission in the last month of life, and ICU admission in the last month of life. ZIP codes were linked to Rural-Urban Commuting Area Codes to create the following categories: metropolitan, micropolitan, small town, and rural categories. We linked ZIP codes to the social deprivation index (SDI), a composite measure of area-level deprivation based on demographic characteristics from the American Community Survey. SDI ranges from 1 (lowest) to 100 (highest) and was classified into quartiles: Q1 (1-25), Q2 (26-50), Q3 (51-75), and Q4 (76-100).We used Pearson’s X2 test to evaluate differences in the distribution of decedent characteristics and PCC. We performed multivariable logistic regression analyses with robust standard errors to evaluate associations between decedent characteristics and PCC. Analyses were conducted using Stata17 (StataCorp). A two-tailed P value <.05 was considered statistically significant.

    Results

    We identified 1,987 decedents with HF (Table 1), of whom 65.6% were White (n=1,303), 32.9% were Black (n=653), and 1.6% identified as another race (n=31). Mean age at death was 78.3 years and was lower among Black than White individuals (71.3 vs 81.8 years, p<.001).Black individuals were more likely than Whites to have a hospice order (38.7% vs 32.1%, p=.003), inotropic therapy (54.4% vs 42.3%, p<.001), and hospital admissions in the last month of life (39.5% vs. 29.7%, p<.001). Median number of ICU days was greater among Black than White individuals (6.18 (IQR: 2.77, 13.8) vs. 3.87 (IQR: 1.93, 8.53) days, p<.001). Black individuals (30.3% vs. 18.3%, p<.001) were more likely to have an ICU stay in the last month of life than white individuals. Black individuals were more likely to die in-hospital than White individuals (40.6% vs. 30.7%, p<.001).Nearly 46% (n=911) of individuals received a PCC (Table 2). Black individuals were more likely than White individuals to receive a PCC (54.8% vs 41%, p<.001). Median time from PCC to death was 38.5 days and was shorter among White versus Black individuals (31.2 vs 51.5 days, p=.001). The proportion of individuals receiving PCCs was 53.2% in 2012, falling to 40.4% in 2018. Nearly 95% of those who received a PCC had an order for hospice.In univariable analyses, Black individuals had greater odds of receiving a PCC than White individuals (OR = 1.73; 95%CI = 1.43-2.09) (Table 2). Relative to White individuals, Black individuals had greater odds of receiving a PCC after adjusting for gender, age at death, insurance, rurality, social deprivation, year of death, and care use (aOR = 1.60; 95%CI = 1.21-2.11). In the adjusted model, individuals from micropolitan areas had lower odds of receiving PCC relative to those from metropolitan areas (aOR = .456; 95%CI = .277-.750). Individuals who received inotropes (aOR = 2.46; 95%CI = 1.98-3.06), had a hospital admission in the last month of life (aOR = 7.15; 95%CI = 5.45-9.40), and had an ICU stay in the last month of life (aOR = 2.29; 95%CI = 1.61-3.26) also had greater odds of receiving a PCC.

    Discussion

    This study found that among individuals who died from HF, Black individuals were more likely to receive PCCs than White individuals even after adjusting for sociodemographic characteristics and healthcare use. Prior research in cancer has found that Black individuals are more likely to receive PCCs than White individuals.8 Greater referrals to PC among minoritized individuals may result from clinician perceptions of severity of illness and greater preferences for life-sustaining treatment and PCCs may be initiated to facilitate goals-of-care conversations. Indeed, our study found that Black decedents were more likely to receive inotropic therapy and received more acute care near the end of life than White decedents. Increased PCCs among Black individuals might also signify reduced access to advanced HF therapies. Younger age may be an additional precipitating factor for PCC, as Black individuals died on average 10 years earlier from HF than White individuals. Many PCCs may have been requested to assist with discussions about hospice and we did find increased likelihood of hospice orders among Black decedents. Clinicians may perceive Black people as having more limited financial and social resources and therefore a greater need for hospice’s services than White individuals thus prompting PCCs for these patients. 8We also observed that PCCs are likely underutilized, and this may be worsening with time. More than 54% of our sample did not receive PCCs and most received PC in the last month or two before death. We also observed a decline in the proportion of individuals receiving PCCs from 2012 to 2018. The drivers of this trend are unknown; however, potential explanations could include greater primary PC provision by cardiologists or limitations in the specialty PC workforce.An important strength of our study is the high proportion of racially-minoritized individuals in our sample, though there are limitations. Data from one health system limits generalizability; however, our results align with findings from studies examining receipt of PCC in other patient populations. Although our study included measures of area-level social deprivation, we lacked individual-level socioeconomic information. We were also unable to determine the reason for PCC as well as patient care preferences. Furthermore, it is possible that deaths from HF may have been undercounted due to errors in ICD coding for primary cause of death. Finally, we were unable to assess granular data on HF severity as well as advanced HF therapy evaluations as this data was assembled via a data warehouse pull.

    Conclusion

    Our analysis found higher rates of PCC among Black decedents from HF. Considering persistent racial inequities in HF incidence and mortality, these findings are encouraging; however, fewer than half of all HF decedents in our sample received a PCC. Given HF’s significant symptom burden, strategies to increase early PC utilization in HF among all groups are needed.
    MODr. Modele Ogunniyi

    Dr. Modele Ogunniyi

    Cardiology · General Non-Invasive Cardiology
    Emory University
    modele